Andrew Kung, MD, PhD

Memorial Sloan Kettering Cancer Center
New York, New York, United States

Disclosure information not submitted.

Presentation(s):

• Paper 05 - SYSTEMATIC CHARACTERIZATION AND TARGETING OF MASTER REGULATOR DEPENDENCIES IN COEXISTING OSTEOSARCOMA SUBPOPULATIONS

  Thursday, November 14, 2024
  8:30 AM – 10:00 AM PST

• Paper 35 - FEASIBILITY OF A HARMONIZED MULTI-SITE PRECLINICAL DRUG TESTING APPROACH BY THE PEDIATRIC RESEARCH IN ONCOLOGY XENOGRAFTING CONSORTIUM (PROXC)

  Thursday, November 14, 2024
  4:45 PM – 5:45 PM PST

• Paper 85 - BREAKING HLA RESTRICTION TO THERAPEUTICALLY TARGET A FUSION-DERIVED PUBLIC NEOANTIGEN IN DESMOPLASTIC SMALL ROUND CELL TUMOR

  Saturday, November 16, 2024
  10:30 AM – 12:00 PM PST